Futura Medical plc develops and commercializes consumer health products focused on sexual health. The company’s lead product, Eroxon®, is a clinically proven topical gel for the treatment of erectile dysfunction, available over the counter in multiple markets including Europe and the USA. Futura is also developing WSD4000, a portfolio of topical gels aimed at addressing female sexual dysfunction. The company operates a hybrid business model that combines research and development with commercial partnerships to enhance market reach and sustainability. Futura is based in Guildford, United Kingdom, and targets global consumer healthcare markets.
Futura Medical plc develops and commercializes consumer health products focused on sexual health. The company’s lead product, Eroxon®, is a clinically proven topical gel for the treatment of erectile dysfunction, available over the counter in multiple markets including Europe and the USA. Futura is also developing WSD4000, a portfolio of topical gels aimed at addressing female sexual dysfunction. The company operates a hybrid business model that combines research and development with commercial partnerships to enhance market reach and sustainability. Futura is based in Guildford, United Kingdom, and targets global consumer healthcare markets.
